Osteonecrosis treatment market also known as aseptic necrosis, is a condition which occurs due to loss of blood flow to the bone. Bone is a living tissue which requires regular supply of blood. Any disruption to the supply of blood can cause the bone to die, and if the process is not stopped in time, it can lead to eventual collapse of the bone. Degenerative arthritis, particularly of the knees and hips and to a lesser extent of the hands, shoulders, and feet, may be caused due to bone collapse. Osteonecrosis is caused due to serious trauma injuries, excess consumption of alcohol, chronic use of corticosteroid, systemic lupus erythematous, decompression disease, blood disorders such as antiphospholipid antibody syndrome (APS), sickle cell anemia, and HIV infection, among others.
Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52395
A prominent factor contributing to the growth of the osteonecrosis treatment market is the rise in consumption of alcohol observed across the globe. In the U.S alone, the number of people consuming alcohol has risen exponentially during the period 2002-03 to 2012-13, according to an independent study conducted by the National Institute on Alcohol Abuse and Alcoholism. The study also finds that the number of female alcohol consumers has more than doubled in the reported time period. Excessive alcohol consumption over a considerable period of time leads to abnormal lipid metabolism, which is a prominent risk factor for alcohol-induced osteonecrosis.
Rise in hip injuries owing to surge in geriatric population is expected to drive the osteonecrosis treatment market during the forecast period. Hip injuries may lead to interruption of flow of blood to the bone, causing trauma-related avascular necrosis. Osteonecrosis may develop in 20% of the people with hip injuries. According to the United Nations’ World Population Ageing report, the number of people above the age of 60 years stood at 962 million in 2017, which is projected to reach 2.1 billion by 2050, globally. Rise in geriatric population is anticipated to increase the number of cases of hip injuries, which in turn, augments the patient population suffering from osteonecrosis. This is likely to drive the demand for medications and therapies used to manage these conditions.
Request for Covid-19 Impact Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=52395
Additionally, ongoing measures undertaken by biotechnology companies aimed at developing novel treatment options for people suffering from osteonecrosis is also expected to drive the growth of the osteonecrosis treatment market. In September 2017, Bone Therapeutics, a biotechnology company engaged in developing cell therapy-based products for bone diseases and orthopedics and Asahi Kasei Corporation, a major chemicals company, entered into an exclusive royalty bearing license agreement for the development and commercialization of PREOB, an autologous bone cell therapy product developed by Bone Therapeutics, in Japan. Such strategic initiatives focused on launch of new and effective treatment options for managing this condition is likely to boost the osteonecrosis treatment market during the forecast period from 2018 to 2026.
The global osteonecrosis treatment market can be segmented based on treatment type, end-user, and region. In terms of treatment type, the market can be classified into non-surgical treatment and surgical treatment. Based on end-user, the osteonecrosis treatment market can be divided into hospitals, ambulatory surgical centers, and orthopedic clinics.
In terms of region, the global osteonecrosis treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global osteonecrosis treatment market due to launch of new treatment options in the region. The osteonecrosis treatment market in Asia Pacific is projected to grow significantly during the forecast period owing to the increase in geriatric population in the region.
Buy Osteonecrosis Treatment Market Report at - https://www.transparencymarketresearch.com/checkout.php?rep_id=52395<ype=S
Key players operating in the global osteonecrosis treatment market include Bone Therapeutics SA, Enzo Biochem Inc, Integra LifeSciences Corporation., and K-Stemcell Co Ltd.
This intelligence report by TMR is the outcome of intense study and rigorous assessment of various dynamics shaping the growth of the market. TMR nurtures a close-knit team of analysts, strategists, and industry experts who offer clients tools, methodologies, and frameworks to make smarter decisions. Our objective, insights, and actionable analytics provide CXOs and executives to advance their mission-critical priorities with confidence.
The scrutiny of the various forces impacting the dynamics of the market, and key and associated industries, guides enterprises in understanding various consumer propositions. Our clients leverage these insights and perspectives to enhance customer experience in the fast-paced business environment.
All our insights and perspectives are broadly based on 4 Pillars or Stages: ASBC-S, which offer an elaborate and customizable framework for the success of an organization. The essence and the roles of these in organizational successes are highlighted below:
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/
Osteonecrosis happens when bones fall apart due to a lack of blood flow.
Osteonecrosis is most commonly observed in hip bones (femurs) or knees, but can also be seen less frequently in shoulders, wrists, ankles, hands, and feet.
According to Bone Therapeutics, approximately 170,000 people in Europe, the U.S., and Japan suffered from osteonecrosis in 2017.
The widespread availability of treatment technology, gene therapy, and stem cell therapy is expected to drive a boom in the osteonecrosis treatment market.
In 2017, osteonecrosis afflicted close to 10,000 to 20,000 Americans between the ages of 20 and 50, according to the American College of Rheumatology.
In the current state of non-surgical treatment aimed at treating osteonecrosis symptoms (signs), surgical treatment is not available.
Osteonecrosis, also known as aseptic necrosis, is a condition which occurs due to loss of blood flow to the bone.
Degenerative arthritis, particularly of the knees and hips and to a lesser extent of the hands, shoulders, and feet, may be caused due to bone collapse.
Osteonecrosis is caused due to serious trauma injuries, excess consumption of alcohol, chronic use of corticosteroid, systemic lupus erythematous, decompression disease, blood disorders such as antiphospholipid antibody syndrome (APS), sickle cell anemia, and HIV infection, among others.
Excessive alcohol consumption over a considerable period of time leads to abnormal lipid metabolism, which is a prominent risk factor for alcohol-induced osteonecrosis.
Request COVID Analysis on Osteonecrosis Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=52395 Rise in hip injuries owing to surge in geriatric population is expected to drive the osteonecrosis treatment market during the forecast period.
According to the United Nations’ World Population Ageing report, the number of people above the age of 60 years stood at 962 million in 2017, which is projected to reach 2.1 billion by 2050, globally.
Consistency in your life style is the Rapid Fast Keto Boost Review key to seeing results from diet and work out plans.
If you have not started yet, start today and do it every day.
Without this mindset, it is very hard to loose and maintain your ideal weight.This is the secret to how to loose weight fast.An estimation is that 70% of adults strive to have a flat tummy but have a problem with losing tummy fat.
They will go through a number of fads, products and latest craze diets before finally giving up because they think that losing tummy fat is a myth.
They will admire models in magazines and then put it all down to air brushing of the photographs.Fortunately losing tummy fat is reality but most of the fads and tricks that tell you how to do it are a myth.
A common myth among men is to work hard on sit ups and forget about losing weight.
Rapid Fast Keto Boost Reviews Over a decade there are a lot of weight loss supplements are introduced to the market with no benefits.
Such types of products don’t give a positive impact on the body.
But this is a weight loss supplement that is used along with keto diet and it increases the ketosis process in the body.
There is no product like because Rapid Fast Keto Boost Reviews is the best product that can reduce weight.The way any of the Rapid Fast Keto Boost Reviews product works is by activating the ketosis phase in your body.
Starting with the first dose of the product, the weight loss pills start the phase of ketosis in our bodies.
In case your body can’t achieve the ketosis phase, you can still use the product since it still works, but not that effective.The main ingredient of the product is the BHB, which is already mentioned in the Rapid Fast Keto Boost Reviews, also works on starting the ketone process in your body.
